SV Health Investors announces the acquisition of Nordic Consulting Partners by Accrete Health Partners, a strategic holding company of Bon Secours Mercy Health

BOSTON, June 8, 2022 /PRNewswire/ — SV Health Investors (“SV”) is pleased to announce the acquisition of Nordic Consulting Partners (“Nordic”) by Accrete Health Partners (“Accrete”), a strategic holding company of Bon Secours Mercy Health .

SV led the majority recapitalization of Nordic in October 2012, as well as Health Enterprise Partners (“HEP”), HLM Venture Partners (“HLM”) and Kaiser Permanente Ventures (“KP Ventures”). In 2016, Silversmith Capital Partners (“Silversmith”) led a minority recapitalization in which SV, HEP, HLM and KP Ventures remained Nordic shareholders.

Based at Madison, Wis., Nordic is a global health and technology consulting company that partners with health leaders around the world to help them harness the power of technology. Nordic’s team of over 1,900 professionals supports more than 600 customers worldwide with innovative solutions, deep clinical expertise and deep technical knowledge.

SV and its co-investors understood from the outset of their investment in Nordic that customer service excellence begins with recruiting smart, passionate professionals who are driven by a culture of support. Nordic’s numerous third-party awards for customer service and workplace culture are a testament to the success of Nordic’s management team in realizing this vision.

Tom Flynn, Managing Partner of SV, said, “Nordic’s success over the past decade reflects its unwavering commitment to employees and customers. We would like to thank the CEO Jim ConstanzoCFO Glenn Cole and the rest of Nordic’s outstanding management team for bringing this vision to life.”

SV Operating Partner and former Nordic President Bruce Cerullo added “Sustainable excellence begins with engaged and supportive shareholders. With SV, HEP, HLM, KP Ventures and Silversmith, Nordic has enjoyed consistent shareholder support.”

SV Health Investors is a growth capital and venture capital firm dedicated to investing in the healthcare and life sciences sector. Founded in 1993 with offices in Boston and LondonSV has about $2.7 billion of assets under management across multiple investment strategies. SV’s dedicated healthcare growth fund – SV7 Growth Fund – seeks to partner with experienced management teams to accelerate the success of innovative healthcare companies in healthcare services, medical products and digital health. SV combines decades of experience in healthcare transactions and operations to drive long-term value creation and achieve the Triple Aim of healthcare – higher quality care, accessible to more patients, to lower cost. For more information, please visit

Health Enterprise Partners ( invests in private, lower-middle-market health services and information technology companies. At the heart of HEP’s strategy is its unique and extensive system of hospitals and its network of health plans, 36 of whose members are investors in HEP’s funds. HEP seeks to invest in companies that improve the quality of the patient experience, expand access and reduce the cost of healthcare.

HLM Venture Partners ( is a leading venture capital firm and one of the oldest and most experienced in the country in the sectors of technology-based health services, health care information and medical and diagnostic devices. Seeking dynamic, emerging growth companies, HLM invests in the most innovative companies in the industry, including more than 100 companies over the past 20 years.

Kaiser Permanente Ventures, founded in 1998 with more than 70 investments to date, is one of the most successful strategic venture capital investment programs in the healthcare industry. KP Ventures team builds on Kaiser Permanente strengths and capabilities $93 billion integrated delivery system to support innovative enterprises. KP Ventures is playing an important role in transforming American healthcare by improving health outcomes, improving the consumer experience and driving affordability, while delivering a highly competitive return on investment. For more information, please visit

Founded in 2015, Silversmith Capital Partners is a Bostongrowth capital company with $2.0 billion capital under management. Silversmith’s mission is to partner with and support the best entrepreneurs in growing and profitable healthcare and technology companies. Representative investments include ActiveCampaign, DistroKid,, Iodine Software, LifeStance Health, and Webflow. Partners have served on the boards of many successful growth companies, including ABILITY Network,, Liberty Dialysis, Passport Health, SurveyMonkey and Wrike. For more information about Silversmith, please visit or follow the company on LinkedIn.

Media contact:
Brent Faduski
Investors SV Health
[email protected]


Back To Top